Investigators analyse factors associated with patient satisfaction after refractive surgery

Ophthalmology Times EuropeOphthalmology Times Europe June 2021
Volume 17
Issue 05

A recent retrospective analysis of LASIK and PRK patients helped to provide insights into patient satisfaction postoperatively. Such analyses might lead to improved patient outcomes.

Investigators analyse factors associated with patient satisfaction after refractive surgery

This article was reviewed by Dr Julie M. Schallhorn.

Patient-reported outcomes (PROs) are critical to gaining an understanding of patient experience after laser vision correction (LVC), with the way the patient perceives the surgical outcome being just as important as the postoperative measurement of visual acuity (VA). Dr Julie Schallhorn, an associate professor of ophthalmology at the University of California, San Francisco, United States, pointed out the need for an appropriate way to measure patient perceptions given the frequent loss to follow-up of the patients who underwent LVC.

To address this need, Dr Schallhorn and her colleagues conducted a retrospective analysis of patients who underwent a primary bilateral LASIK or PRK procedure with targeted emmetropia between July 2014 and June 2016. The investigators analysed the demographic, refractive and PRO data obtained preoperatively and at months 1 and 3 postoperatively. She explained that the goal was to identify factors associated with loss to follow-up, patient satisfaction and completion of the PRO measure.

Related: AI enhances customised myopic LASIK with ray tracing optimisation

Data from about 37,000 patients who underwent a primary LVC were included. Of those, about 68% completed the PRO measure; the percentage at the 1-month visit was 54% and there was a 15% loss to follow-up, and the numbers at 3 months were 28% and 51%.

Data analysis showed that patients who returned for follow-up and completed the PRO measure were more likely to be women. In addition, patients who underwent a PRK and had higher amounts of preoperative ametropia were more likely to return for follow-up and complete the PRO measure.

Related: SMILE procedure offers low enhancement rate after nomogram adjustment

When this information was combined in a multivariant logistic regression model, at month 1, older age (P < 0.001), female sex (P < 0.001), PRK (P < 0.001) and higher amounts of myopic/hyperopic corrections (P = 0.003) were all associated significantly with completion of the PRO measure. “All of that is only important if it affects the patient satisfaction. If those variables have no effect on patient satisfaction, we would not expect them to alter our observations, regardless of loss to follow-up,” Dr Schallhorn said.

The investigators then conducted an analysis of the patient-reported satisfaction in relation to the variables predictive of loss to follow-up and completion of the PRO measure. “At 1 month, myopia/hyperopia, gender, age, procedure and the postoperative binocular uncorrected VA/line below 20/16 all affected the patient satisfaction,” Dr Schallhorn said. By 3 months, all remained significant except for the procedure.

A closer look at PRO after laser vision correction

Regarding age, at both months 1 and 3, the older patients were more likely both to complete the PRO measure and to be dissatisfied with their VA. The preoperative manifest spherical equivalent at 1 month showed no association between the spherical equivalent and completion of the PRO measure; however, at 3 months, patients with higher preoperative myopia and hyperopia were more likely to complete the PRO measure.

“Most importantly, the postoperative VA was predictive of both PRO completion and patient satisfaction,” Dr Schallhorn said. “Patients with worse VA were more likely to complete the PRO measure and were much less likely to be satisfied with their VA.”

Related: When to implant phakic IOLs

Based on this analysis, she concluded that age, sex, preoperative refractive error and postoperative VA all predict patient-reported satisfaction after LASIK and PRK, and all except the last predicted follow-up at 1 and 3 months postoperatively. “Among the patients who completed the follow-up evaluations, the postoperative vision was strongly predictive of patient satisfaction and completion of the PRO measure,” she said.

Related: How to use topography-guided laser procedures to treat keratoconus

Dr Schallhorn noted that ophthalmologists cannot view PRO measures as a simple outcome of surgery and must take a more nuanced view. “Patients who undergo surgery have a visual outcome, and factors from both the visual outcome and intrinsic factors present preoperatively result in either the patients being lost to follow-up or the decision to complete their PRO. The PRO data collection is heavily dependent on factors that influence the outcome,” she said.

Dr Schallhorn added that she advises caution when analysing and interpreting PRO data. She hopes to delve deeper into which factors comprise patient satisfaction postoperatively and how to improve patient outcomes.

Julie M. Schallhorn, MD
This article is adapted from Dr Schallhorn’s presentation at the American Academy of Ophthalmology’s 2020 virtual annual meeting. Dr Schallhorn is a consultant to Carl Zeiss Meditec and Vanda Pharmaceuticals and holds equity in Long Bridge Medical.

Related Content: Cataract & Refractive | Cornea | Carl Zeiss Case Studies

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.